Wakefield Asset Management’s AdvisorShares Pure US Cannabis ETF MSOS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
– Sell
-54,328
Closed -$484K – 172
2022
Q3
$484K Buy
54,328
+35,546
+189% +$410K 0.22% 126
2022
Q2
$194K Sell
18,782
-30,839
-62% -$458K 0.08% 153
2022
Q1
$1.03M Buy
49,621
+13,436
+37% +$293K 0.37% 77
2021
Q4
$926K Buy
+36,185
New +$999K 0.32% 96

Other funds holding MSOS

Wakefield Asset Management's MSOS Position: Q4 2022 in Review

Wakefield Asset Management sold out of AdvisorShares Pure US Cannabis ETF (MSOS) in Q4 2022, closing a stake of 54,328 shares — an estimated $484K sold.

Wakefield Asset Management first reported a position in MSOS in Q4 2021 and held it in 4 quarters. The position peaked at $1.03M in Q1 2022. 176 funds tracked by Wall St. Rank hold MSOS as of Q4 2022.

  • Wakefield Asset Management reported no remaining AdvisorShares Pure US Cannabis ETF position as of Q4 2022 after selling out during the quarter.
  • Wakefield Asset Management sold 54,328 AdvisorShares Pure US Cannabis ETF shares in Q4 2022, an estimated $484K.
  • Wakefield Asset Management first reported a position in AdvisorShares Pure US Cannabis ETF in Q4 2021 and held it in 4 quarters.
  • Wakefield Asset Management's AdvisorShares Pure US Cannabis ETF position peaked at $1.03M in Q1 2022.
  • 176 funds tracked by Wall St. Rank held AdvisorShares Pure US Cannabis ETF as of Q4 2022.

Based on Wakefield Asset Management's 13F filing for Q4 2022, filed 30 Jan 2023.